NuLife Sciences Inc. Stock Price - NULF

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
SMALL CAP BASIC
Monthly Subscription
for only
$30.03
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Nulife Sciences Inc. (QB) NULF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.01 -2.27% 0.43 0.45 0.43 0.45 0.44 16:23:58
Bid Price Ask Price Spread Spread % News
0.15 5 4.85 97.00% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 4,000 $ 0.4350 $ 1.74k 2.09k 0.26 - 1.50
Last Trade Time Type Quantity Stock Price Currency
10:07:50 3,000 $0.43 USD

Nulife Sciences Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 16.12M 37.5M $ -559.27k - -28.83 6.99M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Nulife Sciences Inc. (QB) News

Latest NULF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NULF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.490.490.430.47606607k3k-0.06-12.24%
1 Month0.550.590.430.4889020k2k-0.12-21.82%
3 Months0.4450.60.430.5299020k2k-0.015-3.37%
6 Months0.670.70.40.5788022k2k-0.24-35.82%
1 Year0.25651.50.25650.6759087k5k0.173567.64%
3 Years0.25651.50.25650.6759087k5k0.173567.64%
5 Years0.25651.50.25650.6759087k5k0.173567.64%

Nulife Sciences Inc. (QB) Description

NuLife Sciences Inc. is a biomedical company focused on medical research and technology that has the potential to address significant unmet medical needs in applications including wound care, organ and tissue transplants, regenerative medicine, and cell therapy. NuLife Sciences Inc. operates through two wholly-owned subsidiaries, NuLife Medical and NuLife BioMed. NuLife Medical utilizes a patent protected and unique proprietary method referred to as the "NuLife Technique" for the treatment of chronic wounds that resist closure or healing, such as diabetic foot ulcers and abrasions. NuLife Medical is currently applying the treatment to trial patients in Latin America with the goal of expanding globally, and into the United States. NuLife BioMed focuses on advancing human organ transplant technology that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs. NuLife BioMed utilizes the NuLife Technique and is currently in preclinical trials involving animal studies on its pathway to commercialization. The Company also seeks opportunities to acquire, merge or develop with other technologies with a focus on changing and saving lives. For more information please visit www.nulifesciences.us.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.